Skip to main content
Premium Trial:

Request an Annual Quote

Response Genetics Settles Proxy Contest; Revises Slate of Board Nominees

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Response Genetics today said that it has settled a proxy contest with institutional investor Special Situations Fund and its affiliates, which will result in a new slate of nominees for the firm's board of directors.

The Los Angeles-based molecular diagnostics firm said that under the terms of the settlement, SSF has agreed to terminate its proxy solicitation and to vote for a revised slate of director nominees. That revised slate will include two outside directors previously nominated by SSF.

The nine nominees to be recommended for election at the 2010 annual meeting of shareholders are Response Genetics President and CEO Kathleen Danenberg, Kirk Calhoun, Gary Nusbaum, Michael Serruya, David Smith, Jan Fagerberg, Michael Metzger, Richard van den Broek, and David Wurzer. Van den Broek and Wurzer were the two previous nominees of SSF.

Response Genetics said that it has postponed its scheduled 2010 annual meeting in order to implement terms of the settlement. A date for the rescheduled meeting will be announced in the near future, said Response Genetics.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.